Table 2. Associations between clinical patient characteristics at diagnosis and TSLP plasma levels in HL patients.
| Variable | Number |
TSLP level median (pg/ml) |
P | ||
|---|---|---|---|---|---|
| IPS parameters |
Age, years (n=75) |
< 45 >45 |
52 23 |
80 102 |
0.9 |
|
Gender (n=75) |
Female Male |
39 36 |
58 101 |
0.3 | |
|
Stage (n=75) |
I-III IV |
55 20 |
71 94 |
0.6 | |
|
White blood cell count (n=74) |
≤ 15 x 103/ml > 15 x 103/ml |
59 15 |
45 246 |
0.02 | |
|
Lymphocyte count (n=71) |
≥ 600/ml < 600/ml |
63 8 |
71 112 |
0.7 | |
|
Hemoglobin level (n=74) |
≥ 10.5 g/dl < 10.5 g/dl |
60 14 |
88 80 |
1.0 | |
|
Albumin level (n=73) |
≥ 40 g/l < 40 g/l |
37 36 |
44 117 |
0.3 | |
|
IPS (n=73) |
0-2 3-5 |
48 25 |
44 167 |
0.03 | |
|
Histology subtype (n=75) |
cHL Nodular sclerosis cHL Mixed cellularity cHL NOS NLPHL |
61 1 10 3 |
117 71 63 582 |
0.9 | |
|
B-symptoms (n=75) |
Absent Present |
47 28 |
91 52 |
0.2 |